↑Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
↑ 4,04,1Holland RL, Wesnes K, Dietrich B (1994). „Single dose human pharmacology of umespirone”. European Journal of Clinical Pharmacology46 (5): 461–8. PMID7957544.
↑Ruhland M, Krähling H, Fuchs A, Schön U (November 1988). „KC 9172 (free base of KC 7218)--an antipsychotic/anxiolytic compound. I. Antipsychotic and anxiolytic activity in comparison with chlorpromazine, clozapine, diazepam and buspirone”. Pharmacopsychiatry21 (6): 396–8. DOI:10.1055/s-2007-1017024. PMID2907649.
↑Krähling H, Fuchs A, Ruhland M, Schön U, Mol F, Tulp M (November 1988). „KC 9172 (free base of KC 7218)--an antipsychotic/anxiolytic compound. II. Discrimination from typical neuroleptics and benzodiazepine-like minor tranquilizers”. Pharmacopsychiatry21 (6): 399–401. DOI:10.1055/s-2007-1017025. PMID2907650.
↑ 8,08,1Schmidt WJ, Krähling H, Ruhland M (1991). „Antagonism of AP-5-induced sniffing stereotypy links umespirone to atypical antipsychotics”. Life Sciences48 (6): 499–505. DOI:10.1016/0024-3205(91)90464-M. PMID1671523.
↑ 9,09,1Ahlenius S, Wijkström A (November 1992). „Mixed agonist-antagonist properties of umespirone at neostriatal dopamine receptors in relation to its behavioral effects in the rat”. European Journal of Pharmacology222 (1): 69–74. DOI:10.1016/0014-2999(92)90464-F. PMID1361441.
↑Itzhak Y, Ruhland M, Krähling H (February 1990). „Binding of umespirone to the sigma receptor: evidence for multiple affinity states”. Neuropharmacology29 (2): 181–4. DOI:10.1016/0028-3908(90)90058-Y. PMID1970425.